v3.24.0.1
Consolidated Statements of Changes in Equity (Unaudited) - USD ($)
$ in Thousands
Total Stockholder's Equity
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Treasury Stock
Deferred Compensation
Noncontrolling Interests
Total
Beginning Balance at Oct. 31, 2022 $ 684,392 $ 41 $ 2,094,076 $ (1,407,973) $ (1,752) $ (855) $ 855 $ 7,105 $ 691,497
Beginning Balance at (in shares) at Oct. 31, 2022   405,562,988              
Common stock issued, non-employee compensation 68   68           68
Common stock issued, non-employee compensation (in shares)   21,106              
Stock issued under benefit plans, net of taxes paid upon vesting of restricted stock awards (314)   (314)           (314)
Stock issued under benefit plans, net of taxes paid upon vesting of restricted stock awards (in shares)   169,065              
Share based compensation 2,637   2,637           2,637
Preferred dividends - Series B (800)   (800)           (800)
Effect of foreign currency translation 447       447       447
Adjustment for deferred compensation           (68) 68    
Adjustment for deferred compensation (in shares)   (21,106)              
Reclassification of redeemable non-controlling interest               3,030 3,030
Distribution to non-controlling interest               (106) (106)
Net loss attributable to noncontrolling interests 2,464     2,464       (2,464) 2,464
Net Loss (21,086)     (21,086)         (21,086)
Ending Balance at Jan. 31, 2023 667,808 $ 41 2,095,667 (1,426,595) (1,305) (923) 923 7,565 675,373
Ending Balance at (in shares) at Jan. 31, 2023   405,732,053              
Beginning Balance at Oct. 31, 2023 682,493 $ 45 2,199,661 (1,515,541) (1,672) (1,078) 1,078 17,955 $ 700,448
Beginning Balance at (in shares) at Oct. 31, 2023   450,626,862             450,626,862
Common stock issued, non-employee compensation 51   51           $ 51
Common stock issued, non-employee compensation (in shares)   44,398              
Stock issued under benefit plans, net of taxes paid upon vesting of restricted stock awards (926)   (926)           (926)
Stock issued under benefit plans, net of taxes paid upon vesting of restricted stock awards (in shares)   1,235,192              
Share based compensation 2,876   2,876           2,876
Preferred dividends - Series B (800)   (800)           (800)
Effect of foreign currency translation 33       33       33
Adjustment for deferred compensation           (51) 51    
Adjustment for deferred compensation (in shares)   (44,398)              
Contributions received from sale of noncontrolling interest               25,122 25,122
Distribution to non-controlling interest               (236) (236)
Net loss attributable to noncontrolling interests 24,606     24,606       (24,606) 24,606
Net Loss (44,399)     (44,399)         (44,399)
Ending Balance at Jan. 31, 2024 $ 663,934 $ 45 $ 2,200,862 $ (1,535,334) $ (1,639) $ (1,129) $ 1,129 $ 18,235 $ 682,169
Ending Balance at (in shares) at Jan. 31, 2024   451,862,054             451,862,054